Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Clinical and Experimental Vaccine Research Highlighting Ovarian Cancer Vaccine Technology

SAN JOSE, Calif., June 21, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and preve...

Related Keywords

,Nina Dvorina ,Suparna Mazumder ,Mike Catelani ,Vincentk Tuohy ,Eric Ribner ,Valerie Swank ,Amit Kumar ,Justinm Johnson ,Molgenie Gmb ,Linkedin ,Lifesci Advisors ,National Cancer Institute ,Company Contact ,Moffitt Cancer Center ,Nasdaq ,Prnewswire Anixa Biosciences Inc ,Anixa Biosciences Inc ,Experimental Vaccine Research ,Experimental Vaccine ,Cleveland Clinic ,Anixa Biosciences ,Molgenie Gmbh ,Facebook Forward Looking ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Sci Advisors ,